ClinicalTrials.Veeva

Menu
T

The Education & Research Foundation | Lynchburg, VA

Research site
(Unclaimed)

Site insights

Top conditions

Top treatments

NFX-179
A-101
Upadacitinib
Etrasimod
Setipiprant
PLACEBO-CONTROLLED SAFETY STUDY OF RITLECITINIB
PF-06651600
CNTX-4975
BAY1183345
AGN-151586

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

4 of 36 total trials

A 104-Week Study of Ritlecitinib Oral Capsules in Adults With Nonsegmental Vitiligo (Active and Stable) Tranquillo 2

The purpose of this study is to learn about the safety and effects of the study medicine ritlecitinib for the possible treatment of nonsegmental viti...

Enrolling
Stable Nonsegmental Vitiligo
Active Nonsegmental Vitiligo
Drug: Ritlecitinib
Drug: Placebo

Hidradenitis suppurativa (HS) is an inflammatory skin disease that causes painful lesions in the axilla (underarm), inguinal (groin) and anogenital (...

Enrolling
Hidradenitis Suppurativa
Drug: Upadacitinib
Drug: Placebo

The objective of this study is to assess the efficacy and safety of upadacitinib for the treatment of adolescent and adult participants with moderate...

Active, not recruiting
Atopic Dermatitis
Drug: Upadacitinib
Drug: Placebo for Upadacitinib

This is a Pre-IDE, prospective, multicenter, randomized, parallel-group, double-blind, vehicle- controlled study to evaluate safety and effectiveness...

Enrolling
Distal Lateral Subungual Onychomycosis
Onychomycosis
Device: Nail Genesis DLSO Product
Device: Nail Genesis DLSO Product (vehicle only)

Trial sponsors

Galderma logo
Pfizer logo
AbbVie logo
D
Aclaris Therapeutics logo
N
Allergan logo
Almirall logo
Bayer logo
C

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems